Mediwound Accounts Payable vs Total Liab Analysis

MDWD Stock

USD 18.84 0.43 2.23%

Mediwound financial indicator trend analysis is infinitely more than just investigating Mediwound recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mediwound is a good investment. Please check the relationship between Mediwound Accounts Payable and its Total Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.

Accounts Payable vs Total Liab

Accounts Payable vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mediwound Accounts Payable account and Total Liab. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Mediwound's Accounts Payable and Total Liab is 0.51. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Liab in the same time period over historical financial statements of Mediwound, assuming nothing else is changed. The correlation between historical values of Mediwound's Accounts Payable and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Mediwound are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Accounts Payable i.e., Mediwound's Accounts Payable and Total Liab go up and down completely randomly.

Correlation Coefficient

0.51

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Mediwound obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Mediwound are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Mediwound's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mediwound current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.At present, Mediwound's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 145.2 M, whereas Issuance Of Capital Stock is forecasted to decline to about 21.9 M.

Mediwound fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Common Stock Shares Outstanding		0.42	0.92	0.48	0.55	0.42	0.13	0.98	0.18	-0.73	0.6	0.06	0.28	-0.29	-0.31	0.27	0.36	0.43	-0.04	0.68	-0.15	0.61	0.28	0.98	0.32	-0.48
Total Assets	0.42		0.42	0.64	0.31	0.8	0.3	0.38	-0.48	-0.4	0.32	0.56	-0.18	-0.33	-0.43	0.91	0.32	0.57	0.3	0.72	0.59	0.61	0.41	0.39	0.92	-0.14
Short Long Term Debt Total	0.92	0.42		0.3	0.25	0.49	0.12	0.94	0.23	-0.51	0.31	0.01	0.33	-0.14	-0.25	0.3	0.06	0.27	-0.05	0.57	-0.12	0.4	0.17	0.96	0.31	-0.42
Other Current Liab	0.48	0.64	0.3		0.54	0.33	0.47	0.37	-0.59	-0.6	0.52	0.67	-0.24	-0.48	-0.47	0.59	0.55	0.56	0.38	0.62	0.22	0.68	0.56	0.37	0.64	-0.41
Total Current Liabilities	0.55	0.31	0.25	0.54		0.09	0.08	0.53	-0.13	-0.83	0.94	0.22	-0.18	-0.61	-0.49	0.28	0.6	0.75	0.01	0.62	-0.08	0.85	0.39	0.47	0.35	-0.08
Total Stockholder Equity	0.42	0.8	0.49	0.33	0.09		-0.25	0.42	-0.09	-0.14	0.01	0.23	0.31	0.13	0.04	0.6	0.03	0.22	-0.23	0.4	0.5	0.3	-0.11	0.45	0.58	-0.25
Other Liab	0.13	0.3	0.12	0.47	0.08	-0.25		0.04	-0.61	-0.36	0.27	0.61	-0.67	-0.62	-0.72	0.5	0.38	0.38	0.94	0.47	0.05	0.32	0.88	0.06	0.52	0.03
Property Plant And Equipment Net	0.98	0.38	0.94	0.37	0.53	0.42	0.04		0.25	-0.69	0.57	-0.01	0.32	-0.26	-0.28	0.24	0.23	0.4	-0.12	0.63	-0.17	0.57	0.2	1.0	0.27	-0.45
Net Debt	0.18	-0.48	0.23	-0.59	-0.13	-0.09	-0.61	0.25		0.25	-0.11	-0.96	0.7	0.54	0.55	-0.67	-0.24	-0.47	-0.69	-0.27	-0.33	-0.35	-0.65	0.25	-0.67	-0.08
Retained Earnings	-0.73	-0.4	-0.51	-0.6	-0.83	-0.14	-0.36	-0.69	0.25		-0.87	-0.41	0.31	0.76	0.72	-0.45	-0.66	-0.88	-0.27	-0.73	0.12	-0.92	-0.62	-0.64	-0.52	0.09
Accounts Payable	0.6	0.32	0.31	0.52	0.94	0.01	0.27	0.57	-0.11	-0.87		0.2	-0.22	-0.64	-0.55	0.28	0.68	0.77	0.17	0.74	-0.1	0.87	0.51	0.51	0.37	-0.12
Cash	0.06	0.56	0.01	0.67	0.22	0.23	0.61	-0.01	-0.96	-0.41	0.2		-0.6	-0.58	-0.61	0.73	0.28	0.54	0.67	0.39	0.29	0.46	0.71	-0.01	0.73	-0.06
Non Current Assets Total	0.28	-0.18	0.33	-0.24	-0.18	0.31	-0.67	0.32	0.7	0.31	-0.22	-0.6		0.8	0.82	-0.53	-0.31	-0.57	-0.8	-0.17	-0.27	-0.35	-0.75	0.35	-0.54	-0.56
Non Currrent Assets Other	-0.29	-0.33	-0.14	-0.48	-0.61	0.13	-0.62	-0.26	0.54	0.76	-0.64	-0.58	0.8		0.96	-0.6	-0.48	-0.83	-0.67	-0.51	-0.16	-0.72	-0.85	-0.21	-0.63	-0.25
Other Assets	-0.31	-0.43	-0.25	-0.47	-0.49	0.04	-0.72	-0.28	0.55	0.72	-0.55	-0.61	0.82	0.96		-0.7	-0.45	-0.81	-0.75	-0.56	-0.18	-0.69	-0.89	-0.26	-0.72	-0.29
Cash And Short Term Investments	0.27	0.91	0.3	0.59	0.28	0.6	0.5	0.24	-0.67	-0.45	0.28	0.73	-0.53	-0.6	-0.7		0.29	0.67	0.57	0.63	0.63	0.6	0.64	0.24	0.99	0.08
Net Receivables	0.36	0.32	0.06	0.55	0.6	0.03	0.38	0.23	-0.24	-0.66	0.68	0.28	-0.31	-0.48	-0.45	0.29		0.58	0.34	0.58	-0.02	0.67	0.54	0.2	0.41	0.05
Common Stock Total Equity	0.43	0.57	0.27	0.56	0.75	0.22	0.38	0.4	-0.47	-0.88	0.77	0.54	-0.57	-0.83	-0.81	0.67	0.58		0.37	0.73	0.12	0.95	0.62	0.36	0.72	0.22
Non Current Liabilities Total	-0.04	0.3	-0.05	0.38	0.01	-0.23	0.94	-0.12	-0.69	-0.27	0.17	0.67	-0.8	-0.67	-0.75	0.57	0.34	0.37		0.32	0.27	0.24	0.91	-0.11	0.58	0.14
Inventory	0.68	0.72	0.57	0.62	0.62	0.4	0.47	0.63	-0.27	-0.73	0.74	0.39	-0.17	-0.51	-0.56	0.63	0.58	0.73	0.32		0.05	0.83	0.54	0.62	0.69	-0.11
Other Current Assets	-0.15	0.59	-0.12	0.22	-0.08	0.5	0.05	-0.17	-0.33	0.12	-0.1	0.29	-0.27	-0.16	-0.18	0.63	-0.02	0.12	0.27	0.05		0.06	0.2	-0.16	0.59	-0.02
Other Stockholder Equity	0.61	0.61	0.4	0.68	0.85	0.3	0.32	0.57	-0.35	-0.92	0.87	0.46	-0.35	-0.72	-0.69	0.6	0.67	0.95	0.24	0.83	0.06		0.55	0.53	0.67	-0.02
Total Liab	0.28	0.41	0.17	0.56	0.39	-0.11	0.88	0.2	-0.65	-0.62	0.51	0.71	-0.75	-0.85	-0.89	0.64	0.54	0.62	0.91	0.54	0.2	0.55		0.19	0.68	0.04
Property Plant And Equipment Gross	0.98	0.39	0.96	0.37	0.47	0.45	0.06	1.0	0.25	-0.64	0.51	-0.01	0.35	-0.21	-0.26	0.24	0.2	0.36	-0.11	0.62	-0.16	0.53	0.19		0.27	-0.48
Total Current Assets	0.32	0.92	0.31	0.64	0.35	0.58	0.52	0.27	-0.67	-0.52	0.37	0.73	-0.54	-0.63	-0.72	0.99	0.41	0.72	0.58	0.69	0.59	0.67	0.68	0.27		0.07
Short Term Debt	-0.48	-0.14	-0.42	-0.41	-0.08	-0.25	0.03	-0.45	-0.08	0.09	-0.12	-0.06	-0.56	-0.25	-0.29	0.08	0.05	0.22	0.14	-0.11	-0.02	-0.02	0.04	-0.48	0.07

Click cells to compare fundamentals

Mediwound Account Relationship Matchups

Mediwound fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	3.9M	3.9M	3.9M	5.0M	9.0M	9.5M
Total Assets	40.6M	31.1M	19.7M	50.0M	66.5M	44.6M
Other Current Liab	569K	1.8M	2.4M	5.8M	4.9M	2.9M
Total Current Liabilities	10.4M	8.3M	10.7M	12.1M	10.8M	7.6M
Total Stockholder Equity	15.2M	7.3M	(4.6M)	10.9M	31.6M	33.2M
Other Liab	13.0M	13.8M	12.2M	26.2M	23.6M	15.9M
Property Plant And Equipment Net	4.5M	4.5M	4.0M	3.6M	15.9M	16.7M
Net Debt	(5.2M)	(15.6M)	(9.7M)	(33.0M)	(5.3M)	(5.6M)
Retained Earnings	(125.8M)	(135.0M)	(148.5M)	(168.1M)	(174.8M)	(183.6M)
Accounts Payable	4.1M	3.0M	4.7M	5.7M	5.5M	3.2M
Cash	7.2M	17.4M	11.0M	33.9M	12.0M	21.0M
Non Current Assets Total	5.0M	4.9M	4.8M	4.2M	16.8M	17.6M
Non Currrent Assets Other	6K	(4.9M)	(4.3M)	(3.8M)	183K	306.7K
Other Assets	48K	6K	469K	364K	327.6K	311.2K
Cash And Short Term Investments	29.5M	21.6M	11.0M	33.9M	41.7M	31.9M
Net Receivables	4.6M	3.2M	2.7M	9.5M	4.4M	4.3M
Liabilities And Stockholders Equity	40.6M	31.1M	19.7M	50.0M	66.5M	44.6M
Non Current Liabilities Total	15.0M	15.5M	13.6M	27.0M	16.4M	16.5M
Inventory	1.6M	1.4M	1.2M	2.0M	2.8M	1.7M
Other Current Assets	216K	389K	2.7M	10.0M	722K	685.9K
Other Stockholder Equity	140.9M	142.2M	143.9M	178.9M	206.3M	137.7M
Total Liab	25.4M	23.8M	24.3M	39.1M	27.2M	30.3M
Property Plant And Equipment Gross	4.5M	4.5M	4.0M	3.6M	23.1M	24.2M
Total Current Assets	35.6M	26.2M	15.0M	45.8M	49.7M	38.0M
Accumulated Other Comprehensive Income	(25K)	(17K)	(40K)	(19K)	(5K)	(18.9K)
Intangible Assets	429K	363K	297K	231K	165K	156.8K
Property Plant Equipment	4.5M	4.5M	4.0M	3.6M	4.1M	2.6M
Net Tangible Assets	14.7M	6.9M	(4.9M)	10.7M	9.6M	7.6M
Short Term Investments	0.0	16.9M	22.0M	4.0M	29.7M	31.2M
Current Deferred Revenue	249K	462K	543K	63K	24K	22.8K
Non Current Liabilities Other	11.7M	12.3M	11.8M	10.2M	9.9M	11.3M
Net Invested Capital	15.2M	7.3M	(4.6M)	10.9M	31.6M	33.2M
Net Working Capital	25.2M	17.9M	4.2M	33.8M	38.9M	21.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:

How To Invest In Mediwound

Details

Is Mediwound Stock a good investment?

Details

What is Mediwound's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.

You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Mediwound Stock analysis

When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.

	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios

Is Mediwound's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.75)

Revenue Per Share

2.073

Quarterly Revenue Growth

(0.54)

Return On Assets

(0.17)

Return On Equity

(0.32)

The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mediwound Accounts Payable vs Total Liab Analysis

Accounts Payable vs Total Liab

Accounts Payable vs Total Liab Correlation Analysis

Correlation Coefficient

Accounts Payable

Total Liab

Mediwound fundamental ratios Correlations

Mediwound Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Mediwound fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Mediwound Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Cash And Short Term Investments
Property Plant And Equipment Net	+ 0.98	Common Stock Shares Outstanding
Property Plant And Equipment Gross	+ 0.98	Common Stock Shares Outstanding
Property Plant And Equipment Gross	+ 0.96	Short Long Term Debt Total
Other Assets	+ 0.96	Non Currrent Assets Other

Cash	- 0.96	Net Debt
Other Stockholder Equity	- 0.92	Retained Earnings
Total Liab	- 0.89	Other Assets
Common Stock Total Equity	- 0.88	Retained Earnings
Accounts Payable	- 0.87	Retained Earnings
Total Liab	- 0.85	Non Currrent Assets Other